2 studies found for:    22042958 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Conditions: Breast Adenocarcinoma;   HER2 Positive Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Drug: Aromatase Inhibition Therapy;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Drug: Tamoxifen Citrate;   Biological: Trastuzumab
2 Recruiting Observation of Medical Treatments in MBC HER2-negative Patients
Condition: Metastatic Breast Cancer
Intervention: Other: Observation of treatment management

Indicates status has not been verified in more than two years